No abstract available
MeSH terms
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Amantadine / therapeutic use
-
Animals
-
Benserazide / therapeutic use
-
Carbidopa / therapeutic use
-
Drug Therapy, Combination
-
Dyskinesia, Drug-Induced / etiology
-
Humans
-
Levodopa / administration & dosage
-
Levodopa / adverse effects
-
Levodopa / therapeutic use
-
Monoamine Oxidase Inhibitors / therapeutic use
-
Parasympatholytics / therapeutic use
-
Parkinson Disease* / drug therapy*
-
Parkinson Disease* / etiology
-
Parkinson Disease* / pathology
-
Parkinson Disease, Secondary / chemically induced
-
Parkinson Disease, Secondary / drug therapy
-
Pyridines / poisoning
-
Rats
Substances
-
Monoamine Oxidase Inhibitors
-
Parasympatholytics
-
Pyridines
-
Levodopa
-
Benserazide
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Amantadine
-
Carbidopa